Clinical Trial

A Prospective, Randomized, Blind, Controlled Multicenter Clinical Study Comparing the Effectiveness of Preventive Ventricular Arrhythmia Ablation on the Prognosis After Left Ventricular Assist Device (LVAD) Surgery.

Study acronym: PAVA-LVAD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To compare the preventive effect of preventive ventricular arrhythmia ablation on the composite events 30 days after surgery in the study population. The composite events defined in this study 30 days after surgery include persistent ventricular tachycardia/ventricular fibrillation, all-cause death, mechanical thrombosis and right heart failure.
Trial Details
NCT Number NCT07589738
Lead Sponsor The First Affiliated Hospital of Anhui Medical University
Collaborators: Shenzhen Core Medical Technology CO.,LTD., Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), The First Affiliated Hospital of Bengbu Medical University, Lu'an People's Hospital of Anhui Province, The First Affiliated Hospital of Xuzhou Medical College, First Affiliated Hospital of Wannan Medical College
Conditions CHF - Congestive Heart Failure
Enrollment 90 participants
Start Date 2026-01-31
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-15